Shape-mediated biological effects of mesoporous silica nanoparticles

Journal of Biomedical Nanotechnology

Volumn 10, Issue 10, 2014, Pages 2508-2538

  Hao, Nanjing ^a,b   Li, Laifeng ^a   Tang, Fangqiong ^a  

^a TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Aspect ratio; Biocompatibility; Biodegradation; Drug delivery; Mesoporous silica nanoparticles; Morphology; Shape; Tumor therapy

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; DRUG DELIVERY; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; MORPHOLOGY; SURFACE CHEMISTRY; TUMORS;

BIOLOGICAL PERFORMANCE; BIOMEDICAL APPLICATIONS; FABRICATION TECHNOLOGIES; MESOPOROUS SILICA NANOPARTICLES; PARTICLE SIZE AND SURFACES; PHYSICOCHEMICAL PROPERTY; SHAPE; TUMOR THERAPY;

ASPECT RATIO;

CATIONIC SURFACTANT; FLUORESCEIN ISOTHIOCYANATE; HYDROFLUORIC ACID; MCM 41; MESOPOROUS SILICA NANOPARTICLE; METAL OXIDE; NANOMATERIAL; NANOPARTICLE; POLYSTYRENE; POVIDONE; QUANTUM DOT; SILICON DIOXIDE; UNCLASSIFIED DRUG; BIOMATERIAL;

BIOCOMPATIBILITY; BIODEGRADATION; BIOLOGICAL ACTIVITY; CANCER THERAPY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; HUMAN; HYDROGEN BOND; MORPHOLOGY; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; REVIEW; STATIC ELECTRICITY; ANIMAL; CHEMISTRY; DRUG EFFECTS; POROSITY; ULTRASTRUCTURE;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; HUMANS; NANOPARTICLES; POROSITY; SILICON DIOXIDE;

EID: 84904087632     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1940     Document Type: Review

References (296)

1. C. T. Kresge, M. E. Leonowicz, W. J. Roth, J. C. Vartuli, and J. S. Beck, Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 359, 710 (1992).
2. H. S. Nalwa (ed.), Encyclopedia of Nanoscience and Nanotechnology, American Scientific Publishers, Los Angeles, CA (2004/2011), Vols. 1-25.
3. H. S. Nalwa (ed.), Handbook of Nanostructured Materials and Nanotechnology, Academic Press, San Diego, CA (2000), Vols. 1-5.
4. M. Hartmann, Ordered mesoporous materials for bioadsorption and biocatalysis. Chem. Mater. 17, 4577 (2005).
5. A. Albanese, P. S. Tang, and W. C. W. Chan, The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14, 1 (2012).
6. Z. W. Mao, X. Y. Zhou, and C. Y. Gao, Influence of structure and properties of colloidal biomaterials on cellular uptake and cell functions. Biomater. Sci. 1, 896 (2013).
7. Y. Kuthati, P. J. Sung, C. F. Weng, C.-Y. Mou, and C. H. Lee, Functionalization of mesoporous silica nanoparticles for targeting, biocompatibility, combined cancer therapies and theragnosis. J. Nanosci. Nanotechnol. 13, 2399 (2013).
8. D. Richards and A. Ivanisevic, Inorganic material coatings and their effect on cytotoxicity. Chem. Soc. Rev. 41, 2052 (2011).
9. A. Vinu, K. Z. Hossain, and K. Ariga, Recent advances in functionalization of mesoporous silica. J. Nanosci. Nanotechnol. 5, 347 (2005).
10. M. Q. Wang, J. X. Zhang, Z. M. Yuan, W. Z. Yang, Q. Wu, and H. C. Gu, Targeted thrombolysis by using of magnetic mesoporous silica nanoparticles. J. Biomed. Nanotechnol. 8, 624 (2012).
11. C. K. Hong, J. Lee, Y. B. Jang, T. H. Kim, J. G. Yeo, and Y. S. Ahn, Adsorption of water on mesoporous silica for heat management: Effect of pore structure. J. Nanosci. Nanotechnol. 8, 5471 (2008).
12. Y. L. Liu, J. F. Tan, A. Thomas, D. Ou-Yang, and V. R. Muzykantov, The shape of things to come: Importance of design in nanotechnology for drug delivery. Ther. Deliv. 3, 181 (2012).
13. S. E. A. Gratton, P. A. Ropp, P. D. Pohlhaus, J. C. Luft, V. J. Madden, and M. E. Napier, The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. USA 105, 11613 (2008).
14. Y. Geng, P. Dalhaimer, S. S. Cai, R. Tsai, M. Tewari, and T. Minko, Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2, 249 (2007).
15. H. W. Shim, I. S. Cho, K. S. Hong, W. I Cho, and D. W. Kim, Li electroactivity of iron (II) tungstate nanorods. Nanotechnology 21, 465602 (2010).
16. G. Von Maltzahn, J. H. Park, A. Agrawal, N. K. Bandaru, S. K. Das, and M. J. Sailor, Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res. 69, 3892 (2009).
17. Q. J. He and J. L. Shi, Mesoporous silica nanoparticle based nano drug delivery systems: Synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J. Mater. Chem. 21, 5845 (2011).
18. K. Shiba, N. Shimura, and M. Ogawa, Mesoporous silica spherical particles. J. Nanosci. Nanotechnol. 13, 2483 (2013).
19. X. Du and J. H. He, Spherical silica micro/nanomaterials with hierarchical structures: Synthesis and applications. Nanoscale 3, 3984 (2011).
20. D. O. Volkov, J. Benson, Y. Y. Kievsky, and I. Sokolov, Towards understanding of shape formation mechanism of mesoporous silica particles. Phys. Chem. Chem. Phys. 12, 341 (2010).
21. I. Sokolov, H. Yang, G. A. Ozin, and C. T. Kresge, Radial patterns in mesoporous silica. Adv. Mater. 11, 636 (1999).
22. S. M. Yang, H. Yang, N. Coombs, I. Sokolov, C. T. Kresge, and G. A. Ozin, Morphokinetics: Growth of mesoporous silica curved shapes. Adv. Mater. 11, 52 (1999).
23. S. P. Naik and I. Sokolov, Room temperature synthesis of nanoporous silica spheres and their formation mechanism. Solid State Commun. 144, 437 (2007).
24. Q. Cai, Z. S. Luo, W. Q. Pang, Y. W. Fan, X. H. Chen, and F. Z. Cui, Dilute solution routes to various controllable morphologies of MCM-41 silica with a basic medium. Chem. Mater. 10, 258 (2001).
25. X. L. Pang, J. N. Gao, and F. Q. Tang, Controlled preparation of rod- and top-like MCM-41 mesoporous silica through one-step route. J. Non-Crystalline Solids. 351, 1705 (2005).
26. E. M. Björk, F. Söderlind, and M. Odén, Tuning the shape of mesoporous silica particles by alterations in parameter space: From rods to platelets. Langmuir 29, 13551 (2013).
27. D. Sen Karaman, D. Desai, R. Senthilkumar, E. M. Johansson, N. Råtts, and M. Odén, Shape engineering versus organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization. Nanoscale Res. Lett. 7, 358 (2012).
28. H. Jin, Z. Liu, T. Ohsuna, O. Terasaki, Y. Inoue, and K. Sakamoto, Control of morphology and helicity of chiral mesoporous silica. Adv. Mater. 18, 593 (2006).
29. X. L. Pang and F. Q. Tang, Morphological control of mesoporous materials using inexpensive silica sources. Micropor. Mesopor. Mater. 85, 1 (2005).
30. H. M. Chen and J. H. He, Fine control over the morphology and structure of mesoporous silica nanomaterials by a dual-templating approach. Chem. Commun. 44, 4422 (2008).
31. G. Lelong, S. Bhattacharyya, S. Kline, T. Cacciaguerra, M. A. Gonzalez, and M. L. Saboungi, Effect of surfactant concentration on the morphology and texture of MCM-41 materials. J. Phys. Chem. C 112, 10674 (2008).
32. S. Huh, J. W. Wiench, J. C. Yoo, M. Pruski, and V. S. Y. Lin, Organic functionalization and morphology control of mesoporous silicas via a co-condensation synthesis method. Chem. Mater. 15, 4247 (2003).
33. S. Huh, J. W. Wiench, B. G. Trewyn, S. Song, M. Pruski, and V. S. Y. Lin, Tuning of particle morphology and pore properties in mesoporous silicas with multiple organic functional groups. Chem. Commun. 2, 2364 (2003).
34. S. P. Naik, S. P. Elangovan, T. Okubo, and I. Sokolov, Morphology control of mesoporous silica particles. J. Phys. Chem. C 111, 11168 (2007).
35. H. Meng, S. Yang, Z. X. Li, T. Xia, J. Chen, and Z. X. Ji, Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano 5, 4434 (2011).
36. T. Yu, A. Malugin, and H. Ghandehari, Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 5, 5717 (2011).
37. L. Zhang, S. Z. Qiao, Y. G. Jin, L. N. Cheng, Z. F. Yan, and G. Q. Lu, Hydrophobic functional group initiated helical mesostructured silica for controlled drug release. Adv. Funct. Mater. 18, 3834 (2008).
38. I. I. Slowing, J. L. Vivero-Escoto, B. G. Trewyn, and V. S. Y. Lin, Mesoporous silica nanoparticles: Structural design and applications. J. Mater. Chem. 20, 7924 (2010).
39. J. S. Kim, T. J. Yoon, K. N. Yu, M. S. Noh, M. Woo, and B. G. Kim, Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells. J. Vet. Sci. 7, 321 (2006).
40. D. M. Huang, Y. Hung, B. S. Ko, S. C. Hsu, W. H. Chen, and C. L. Chien, Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: Implication for stem cell tracking. FASEB J. 19, 2014 (2005).
41. B. G. Trewyn, J. A. Nieweg, Y. N. Zhao, and V. S. Y. Lin, Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration. Chem. Eng. J. 137, 23 (2008).
42. X. L. Huang, L. L. Li, T. L. Liu, N. J. Hao, H. Y. Liu, and D. Chen, The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 5, 5390 (2011).
43. J. Liu, S. Z. Qiao, J. S. Chen, X. W. Lou, X. R. Xing, and G. Q. Lu, Yolk/shell nanoparticles: New platforms for nanoreactors, drug delivery and lithium-ion batteries. Chem. Commun. 47, 12578 (2011).
44. X. W. (David) Lou, L. A. Archer, and Z. C. Yang, Hollow micro-/nanostructures: Synthesis and applications. Adv. Mater. 20, 3987 (2008).
45. F. Q. Tang, L. L. Li, and D. Chen, Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv. Mater. 24, 1504 (2012).
46. Y. Chen, H. R. Chen, D. P. Zeng, Y. B. Tian, F. Chen, and J. W. Feng, Core/shell structured hollow mesoporous nanocapsules: A potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano 4, 6001 (2010).
47. Y. F. Zhu, Y. Fang, L. Borchardt, and S. Kaskel, PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles. Micropor. Mesopor. Mater. 141, 199 (2011).
48. G. G. Qi, Y. B. Wang, L. Estevez, A. K. Switzer, X. N. Duan, and X. F. Yang, Facile and scalable synthesis of monodispersed spherical capsules with a mesoporous shell. Chem. Mater. 22, 2693 (2010).
49. F. Caruso, R. A. Caruso, and H. Mohwald, Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating. Science 282, 1111 (1998).
50. M. Chen, L. Wu, S. Zhou, and B. You, A method for the fabrication of monodisperse hollow silica spheres. Adv. Mater. 18, 801 (2006).
51. J. J. L. M. Cornelissen, E. F. Connor, H. C. Kim, V. Y. Lee, T. Magibitang, and P. M. Rice, Versatile synthesis of nanometer sized hollow silica spheres. Chem. Commun. 2, 1010 (2003).
52. Q. Zhang, J. P. Ge, J. Goebl, Y. X. Hu, Z. Da Lu, and Y. D. Yin, Rattle-type silica colloidal particles prepared by a surface-protected etching process. Nano Res. 2, 583 (2010).
53. X. J. Wu and D. S. Xu, Formation of Yolk/SiO(2) shell structures using surfactant mixtures as template. J. Am. Chem. Soc. 131, 2774 (2009).
54. X. J. Wu and D. S. Xu, Soft template synthesis of Yolk/silica shell particles. Adv. Mater. 22, 1516 (2010).
55. J. Li, J. Liu, D. H. Wang, R. S. Guo, X. L. Li, and W. Qi, Interfacially controlled synthesis of hollow mesoporous silica spheres with radially oriented pore structures. Langmuir 26, 12267 (2010).
56. Y. S. Lin, S. H. Wu, C. T. Tseng, Y. Hung, C. Chang, and C. Y. Mou, Synthesis of hollow silica nanospheres with a microemulsion as the template. Chem. Commun. 24, 3542 (2009).
57. M. Fujiwara, K. Shiokawa, I. Sakakura, and Y. Nakahara, Silica hollow spheres with nano-macroholes like diatomaceous earth. Nano Lett. 6, 2925 (2006).
58. C. I. Zoldesi and A. Imhof, Synthesis of monodisperse colloidal spheres, capsules, and microballoons by emulsion templating. Adv. Mater. 17, 924 (2005).
59. C. I. Zoldesi, C. A. van Walree, and A. Imhof, Deformable hollow hybrid silica/siloxane colloids by emulsion templating. Langmuir 22, 4343 (2006).
60. H. J. Hah, J. S. Kim, B. J. Jeon, S. M. Koo, and Y. E. Lee, Simple preparation of monodisperse hollow silica particles without using templates. Chem. Commun. 14, 1712 (2003).
61. Y. Q. Yeh, B. C. Chen, H. P. Lin, and C. Y. Tang, Synthesis of hollow silica spheres with mesostructured shell using cationic-anionic-neutral block copolymer ternary surfactants. Langmuir 22, 6 (2006).
62. Z. Feng, Y. Li, D. Niu, L. Li, W. Zhao, and H. Chen, A facile route to hollow nanospheres of mesoporous silica with tunable size. Chem. Commun. 23, 2629 (2008).
63. B. Y. Du, Z. Cao, Z. B. Li, A. X. Mei, X. H. Zhang, and J. J. Nie, One-pot preparation of hollow silica spheres by using thermosensitive poly(N-isopropylacrylamide) as a reversible template. Langmuir 25, 12367 (2009).
64. A. Khanal, Y. Inoue, M. Yada, and K. Nakashima, Synthesis of silica hollow nanoparticles templated by polymeric micelle with core-shell-corona structure. J. Am. Chem. Soc. 129, 1534 (2007).
65. Q. S. Huo, J. Liu, L. Q. Wang, Y. B. Jiang, T. N. Lambert, and E. Fang, A new class of silica cross-linked micellar core-shell nanoparticles. J. Am. Chem. Soc. 128, 6447 (2006).
66. J. Liu, Q. H. Yang, L. Zhang, H. Q. Yang, J. S. Gao, and C. Li, Organic-inorganic hybrid hollow nanospheres with microwindows on the shell. Chem. Mater. 20, 4268 (2008).
67. J. Liu, S. Y. Bai, H. Zhong, C. Li, and Q. H. Yang, Tunable assembly of organosilica hollow nanospheres. J. Phys. Chem. C 114, 953 (2010).
68. D. Jin, K. W. Park, J. H. Lee, K. Song, J. G. Kim, and M. L. Seo, The selective immobilization of curcumin onto the internal surface of mesoporous hollow silica particles by covalent bonding and its controlled release. J. Mater. Chem. 21, 3641 (2011).
69. J. Liu, S. Z. Qiao, S. Budi Hartono, and G. Q. Lu, Monodisperse Yolk-shell nanoparticles with a hierarchical porous structure for delivery vehicles and nanoreactors. Angew. Chem. Int. Ed. 122, 5101 (2010).
70. S. S. Kim, W. H. Zhang, and T. J. Pinnavaia, Ultrastable mesostructured silica vesicles. Science 282, 1302 (1998).
71. B. D. H. W. Hubert, M. Jung, P. M. Frederik, P. H. H. Bomans, J. Meuldijk, and A. L. German, Vesicle-directed growth of silica. Adv. Mater. 75, 1286 (2000).
72. H. P. Hentze, S. R. Raghavan, C. A. Mckelvey, and E. W. Kaler, Silica hollow spheres by templating of catanionic vesicles. Langmuir 19, 1069 (2003).
73. H. Djojoputro, X. F. Zhou, S. Z. Qiao, L. Z. Wang, C. Z. Yu, and G. Q. Lu, Periodic mesoporous organosilica hollow spheres with tunable wall thickness. J. Am. Chem. Soc. 128, 6320 (2006).
74. J. Wang, Q. Xiao, H. Zhou, P. Sun, Z. Yuan, and B. Li, Budded, Mesoporous silica hollow spheres: Hierarchical structure controlled by kinetic self-assembly. Adv. Mater. 18, 3284 (2006).
75. E. Prouzet, F. Cot, C. Boissière, P. J. Kooyman, and A. Larbot, Nanometric hollow spheres made of MSU-X-type mesoporous silica. J. Am. Chem. Soc. 12, 1553 (2002).
76. R. K. Rana, Y. Mastai, and A. Gedanken, Acoustic cavitation leading to the morphosynthesis of mesoporous silica vesicles. Adv. Mater. 14, 1414 (2002).
77. T. R. Zhang, J. P. Ge, Y. X. Hu, Q. Zhang, S. Aloni, and Y. D. Yin, Formation of hollow silica colloids through a spontaneous dissolution-regrowth process. Angew. Chem. Int. Ed. 47, 5806 (2008).
78. C. H. Zeng, Ostwald ripening: A synthetic approach for hollow nanomaterials. Curr. Nanosci. 3, 177 (2007).
79. H. C. Zeng, Synthetic architecture of interior space for inorganic nanostructures. J. Mater. Chem. 16, 649 (2006).
80. T. R. Zhang, Q. Zhang, J. P. Ge, J. Goebl, M. W. Sun, Y. S. Yan, A self-templated route to hollow silica microspheres. J. Phys. Chem. C 113, 3168 (2009).
81. Q. Zhang, T. R. Zhang, J. P. Ge, and Y. D. Yin, Permeable silica shell through surface-protected etching. Nano Lett. 8, 2867 (2008).
82. S. J. Park, Y. J. Kim, and S. J. Park, Size-dependent shape evolution of silica nanoparticles into hollow structures. Langmuir 24, 12134 (2008).
83. Q. Y. Yu, P. P. Wang, S. Hu, J. F. Hui, J. Zhuang, and X. Wang, Hydrothermal synthesis of hollow silica spheres under acidic conditions. Langmuir 27, 7185 (2011).
84. D. Chen, L. L. Li, F. Q. Tang, and S. Qi, Facile and scalable synthesis of tailored silica nanorattle structures. Adv. Mater. 21, 3804 (2009).
85. S. H. Wu, Y. Hung, and C. Y. Mou, Mesoporous silica nanoparticles as nanocarriers. Chem. Commun. 47, 9972 (2011).
86. J. Liu, F. Liu, K. Gao, J. S. Wu, and D. F. Xue, Recent developments in the chemical synthesis of inorganic porous capsules. J. Mater. Chem. 19, 6073 (2009).
87. Y. Zhao and L. Jiang, Hollow micro/nanomaterials with multilevel interior structures. Adv. Mater. 21, 3621 (2009).
88. V. V. Sokolova, I. Radtke, R. Heumann, and M. Epple, Effective transfection of cells with multishell calcium phosphate-DNA nanoparticles. Biomaterials 27, 3147 (2006).
89. L. J. Han, R. J. Liu, C. S. Li, H. H. Li, C. X. Li, and G. J. Zhang, Controlled synthesis of double-shelled CeO2 hollow spheres and enzyme-free electrochemical bio-sensing properties for uric acid. J. Mater. Chem. 22, 17079 (2012).
90. C. F. Zhang, H. Bin Wu, C. Z. Yuan, Z. P. Guo, and X. W. Lou, Confining sulfur in double-shelled hollow carbon spheres for lithium-sulfur batteries. Angew. Chem. Int. Ed. 51, 9592 (2012).
91. X. Y. Lai, J. Li, B. A. Korgel, Z. H. Dong, Z. M. Li, and F. B. Su, General synthesis and gas-sensing properties of multiple-shell metal oxide hollow microspheres. Angew. Chem. Int. Ed. 50, 2738 (2011).
92. J. Liu, S. B. Hartono, Y. G. Jin, Z. Li, G. Q. Lu, and S. Z. Qiao, A facile vesicle template route to multishelled mesoporous silica hollow nanospheres. J. Mater. Chem. 20, 4595 (2010).
93. M. Yang, J. Ma, C. L. Zhang, Z. Z. Yang, and Y. F. Lu, General synthetic route toward functional hollow spheres with double-shelled structures. Angew. Chem. Int. Ed. 117, 6885 (2005).
94. H. L. Xu and W. Z. Wang, Template synthesis of multishelled Cu 2O hollow spheres with a single-crystalline shell wall. Angew. Chem. Int. Ed. 46, 1489 (2007).
95. C. Wong, T. Stylianopoulos, J. Cui, J. Martin, V. P. Chauhan, and W. Jiang, Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc. Natl. Acad. Sci. USA 108, 2426 (2011).
96. U. Kedar, P. Phutane, S. Shidhaye, and V. Kadam, Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 6, 714 (2010).
97. G. L. Li, Q. Shi, S. J. Yuan, K. G. Neoh, E. T. Kang, and X. L. Yang, Alternating silica/polymer multilayer hybrid microspheres templates for double-shelled polymer and inorganic hollow microstructures. Chem. Mater. 22, 1309 (2010).
98. Y. J. Wong, L. F. Zhu, W. S. Teo, Y. W. Tan, Y. H. Yang, and C. Wang, Revisiting the Stöber method: Inhomogeneity in silica shells. J. Am. Chem. Soc. 133, 11422 (2011).
99. C. C. Huang, W. Huang, and C. S. Yeh, Shell-by-shell synthesis of multishelled mesoporous silica nanospheres for optical imaging and drug delivery. Biomaterials 32, 556 (2011).
100. Y. Chen, H. Chen, M. Ma, F. Chen, L. Guo, and L. Zhang, Double mesoporous silica shelled spherical/ellipsoidal nanostructures: Synthesis and hydrophilic/hydrophobic anticancer drug delivery. J. Mater. Chem. 21, 5290 (2011).
101. L. F. Tan, T. L. Liu, L. L. Li, H. Y. Liu, X. L. Wu, and F. P. Gao, Uniform double-shelled silica hollow spheres: Acid/base selective-etching synthesis and their drug delivery application. RSC Adv. 3, 5649 (2013).
102. S. H. Hu, Y. Y. Chen, T. C. Liu, T. H. Tung, D. M. Liu, and S. Y. Chen, Remotely nano-rupturable Yolk/shell capsules for magnetically-triggered drug release. Chem. Commun. 47, 1776 (2011).
103. X. F. Zhang, L. Clime, H. Roberge, F. Normandin, L. H. Yahia, and E. Sacher, pH-triggered doxorubicin delivery based on hollow nanoporous silica nanoparticles with free-standing superparamagnetic Fe3O4 cores. J. Phys. Chem. C 115, 1436 (2011).
104. D. Niu, Y. Li, Z. Ma, H. Diao, J. Gu, and H. Chen, Preparation of uniform, water-soluble, and multifunctional nanocomposites with tunable sizes. Adv. Funct. Mater. 20, 773 (2010).
105. C. P. Tsai, Y. Hung, Y. H. Chou, D. M. Huang, J. K. Hsiao, and C. Chang, High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe. Small 4, 186 (2008).
106. J. Kim, J. E. Lee, J. Lee, J. H. Yu, B. C. Kim, and K. An, Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J. Am. Chem. Soc. 128, 688 (2006).
107. Z. Da Lu, C. B. Gao, Q. Zhang, M. F. Chi, J. Y. Howe, and Y. D. Yin, Direct assembly of hydrophobic nanoparticles to multifunctional structures. Nano Lett. 11, 3404 (2011).
108. H. H. P. Yiu, H. J. Niu, E. Biermans, G. van Tendeloo, and M. J. Rosseinsky, Designed multifunctional nanocomposites for biomedical applications. Adv. Funct. Mater. 20, 1599 (2010).
109. J. E. Lee, N. Lee, H. Kim, J. Kim, S. H. Choi, and J. H. Kim, Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J. Am. Chem. Soc. 132, 552 (2010).
110. Y. Chen, H. R. Chen, Y. Sun, Y. Y. Zheng, D. P. Zeng, and F. Li, Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angew. Chem. Int. Ed. 50, 12505 (2011).
111. F. H. Chen, L. M. Zhang, Q. T. Chen, Y. Zhang, and Z. J. Zhang, Synthesis of a novel magnetic drug delivery system composed of doxorubicin-conjugated Fe3O4 nanoparticle cores and a PEG-functionalized porous silica shell. Chem. Commun. 46, 8633 (2010).
112. B. S. Chang, J. Guo, C. Y. Liu, J. Qian, and W. L. Yang, Surface functionalization of magnetic mesoporous silica nanoparticles for controlled drug release. J. Mater. Chem. 20, 9941 (2010).
113. C. Wang, S. Y. Tao, W. Wei, C. G. Meng, F. Y. Liu, and M. Han, Multifunctional mesoporous material for detection, adsorption and removal of Hg2+ in aqueous solution. J. Mater. Chem. 20, 4635 (2010).
114. X. L. Xing, X. X. He, J. F. Peng, K. M. Wang, and W. H. Tan, Uptake of silica-coated nanoparticles by HeLa cells. J. Nanosci. Nanotechnol. 5, 1688 (2005).
115. Y. S. Lin and C. L. Haynes, Synthesis and characterization of biocompatible and size-tunable multifunctional porous silica nanoparticles. Chem. Mater. 21, 3979 (2009).
116. M. Liong, J. Lu, M. Kovochich, T. Xia, S. G. Ruehm, and A. E. Nel, Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2, 889 (2008).
117. H. Y. Liu, D. Chen, L. L. Li, T. L. Liu, L. F. Tan, and X. L. Wu, Multifunctional gold nanoshells on silica nanorattle: A novel potential platform for combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew. Chem. Int. Ed. 50, 891 (2011).
118. L. F. Tan, D. Chen, H. Y. Liu, and F. Q. Tang, A silica nanorattle with a mesoporous shell: An ideal nanoreactor for the preparation of tunable gold cores. Adv. Mater. 22, 4885 (2010).
119. X. L. Wu, L. F. Tan, D. Chen, X. L. He, H. Y. Liu, and X. W. Meng, Alkylaminosilane-assisted simultaneous etching and growth route to synthesise metal nanoparticles encapsulated by silica nanorattles. Chem. Eur. J. 18, 15669 (2012).
120. X. L. Wu, L. F. Tan, D. Chen, X. W. Meng, and F. Q. Tang, Icosahedral gold-platinum alloy nanocrystals in hollow silica: A highly active and stable catalyst for Ullmann reactions. Chem. Commun. 50, 539 (2013).
121. L. Qiang, X. W. Meng, L. L. Li, D. Chen, X. L. Ren, and H. Y. Liu, Preparation of magnetic rattle-type silica through a general and facile pre-shell-post-core process for simultaneous cancer imaging and therapy. Chem. Commun. 49, 7902 (2013).
122. X. L. He, L. F. Tan, D. Chen, X. L. Wu, X. L. Ren, and Y. Q. Zhang, Fe3O4-Au@mesoporous SiO2 microspheres: An ideal artificial enzymatic cascade system. Chem. Commun. 49, 4643 (2013).
123. B. Godin, J. H. Gu, R. E. Serda, R. Bhavane, E. Tasciotti, and C. Chiappini, Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J. Biomed. Mater. Res. A 94, 1236 (2010).
124. E. Tasciotti, X. W. Liu, R. Bhavane, K. Plant, A. D. Leonard, and B. K. Price, Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat. Nanotechnol. 3, 151 (2008).
125. Z. F. Dai, W. J. Tian, X. L. Yue, Z. Z. Zheng, J. J. Qi, and N. Tamai, Efficient fluorescence resonance energy transfer in highly stable liposomal nanohybrid cerasome. Chem. Commun. 15, 2032 (2009).
126. Z. Cao, X. L. Yue, Y. S. Jin, X. Y. Wu, and Z. F. Dai, Modulation of release of paclitaxel from composite cerasomes. Colloid. Surfaces B Biointerf. 98, 97 (2012).
127. X. L. Liang, X. Da Li, L. J. Jing, P. Xue, L. D. Jiang, and Q. S. Ren, Design and synthesis of lipidic organoalkoxysilanes for the self-assembly of liposomal nanohybrid cerasomes with controlled drug release properties. Chem. Eur. J. 19, 16113 (2013).
128. Y. S. Jin, X. L. Yue, Q. Y. Zhang, X. Y. Wu, Z. Cao, and Z. F. Dai, Cerasomal doxorubicin with long-term storage stability and controllable sustained release. Acta Biomater. 8, 3372 (2012).
129. X. L. Liang, X. L. Yue, Z. F. Dai, and J. Kikuchi, Photoresponsive liposomal nanohybrid cerasomes. Chem. Commun. 47, 4751 (2011).
130. J. Zhao, Z. Hua, Z. Liu, Y. Li, L. Guo, and W. Bu, Direct fabrication of mesoporous zeolite with a hollow capsular structure. Chem. Commun. 48, 7578 (2009).
131. G. Sharma, D. T. Valenta, Y. Altman, S. Harvey, H. Xie, and S. Mitragotri, Polymer particle shape independently influences binding and internalization by macrophages. J. Control Release 147, 408 (2010).
132. Y. Chen, H. Chen, L. Guo, Q. He, F. Chen, and J. Zhou, Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy. ACS Nano 4, 529 (2010).
133. X. H. Shi, A. von dem Bussche, R. H. Hurt, A. B. Kane, and H. J. Gao, Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. Nat. Nanotechnol. 6, 714 (2011).
134. P. P. Yang, S. L. Gai, and J. Lin, Functionalized mesoporous silica materials for controlled drug delivery. Chem. Soc. Rev. 41, 3679 (2012).
135. H. J. Gao, W. D. Shi, and L. B. Freund, Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 102, 3 (2005).
136. R. Vácha, F. J. Martinez-Veracoechea, and D. Frenkel, Receptor-mediated endocytosis of nanoparticles of various shapes. Nano Lett. 11, 5391 (2011).
137. S. Lee, M. Ferrari, and P. Decuzzi, Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology 20, 495101 (2009).
138. S. Shah, Y. L. Liu, W. Hu, and J. M. Gao, Modeling particle shape-dependent dynamics in nanomedicine. J. Nanosci. Nanotechnol. 11, 919 (2011).
139. P. Decuzzi and M. Ferrari, The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials 28, 2915 (2007).
140. K. Yang and Y. Q. Ma, Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat. Nanotechnol. 5, 579 (2010).
141. J. Rejman, V. Oberle, I. S. Zuhorn, and D. Hoekstra, Size-dependent internalization of particles via the pathways of clathrinand caveolae-mediated endocytosis. Biochem. J. 377, 159 (2004).
142. B. D. Chithrani and W. C. W. Chan, Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 7, 1542 (2007).
143. W. Jiang, B. Y. S. Kim, J. T. Rutka, and W. C. W. Chan, Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 3, 145 (2008).
144. D. L. J. Thorek and A. Tsourkas, Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29, 3583 (2008).
145. F. Osaki, T. Kanamori, S. Sando, T. Sera, and Y. Aoyama, A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. J. Am. Chem. Soc. 126, 6520 (2004).
146. A. Natarajan, C. Gruettner, R. Ivkov, G. L. DeNardo, G. Mirick, and A. Yuan, NanoFerrite particle based radioimmunonanoparticles: Binding affinity and in vivo pharmacokinetics. Bioconjugate Chem. 19, 1211 (2008).
147. T. H. Chung, S. H. Wu, M. Yao, C. W. Lu, Y. S. Lin, and Y. Hung, The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28, 2959 (2007).
148. S. R. Blumen, K. Cheng, M. E. Ramos-Nino, D. J. Taatjes, D. J. Weiss, and C. C. Landry, Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells. Am. J. Respir. Cell Mol. Biol. 36, 333 (2007).
149. Q. He, J. Shi, F. Chen, M. Zhu, and L. Zhang, An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 31, 3335 (2010).
150. T. Suteewong, H. Sai, R. Cohen, S. T. Wang, M. Bradbury, and B. Baird, Highly aminated mesoporous silica nanoparticles with cubic pore structure. J. Am. Chem. Soc. 133, 172 (2011).
151. M. Fisichella, H. Dabboue, S. Bhattacharyya, G. Lelong, M. L. Saboungi, and F. Warmont, Uptake of functionalized mesoporous silica nanoparticles by human cancer cells. J. Nanosci. Nanotechnol. 10, 2314 (2010).
152. Y. Qiu, Y. Liu, L. M. Wang, L. G. Xu, R. Bai, and Y. L. Ji, Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31, 7606 (2010).
153. R. Choi, J. Yang, J. Choi, E. K. Lim, E. Kim, and J. S. Suh, Thiolated dextran-coated gold nanorods for photothermal ablation of inflammatory macrophages. Langmuir 7, 17520 (2010).
154. J. D. Wang, Z. G. Teng, Y. Tian, T. Fang, J. Ma, and J. Sun, Increasing cellular uptake of mesoporous silica nanoparticles in human embryonic kidney cell line 293T cells by using Lipofectamine 2000. J. Biomed. Nanotechnol. 9, 1882 (2013).
155. Z. M. Tao, M. P. Morrow, T. Asefa, K. K. Sharma, C. Duncan, and A. Anan, Mesoporous silica nanoparticles inhibit cellular respiration. Nano Lett. 8, 1517 (2008).
156. S. P. Hudson, R. F. Padera, R. Langer, and D. S. Kohane, The biocompatibility of mesoporous silicates. Biomaterials 29, 4045 (2008).
157. M. Al Shamsi, M. T. Al Samri, S. Al-Salam, W. Conca, S. Shaban, and S. Benedict, Biocompatibility of calcined mesoporous silica particles with cellular bioenergetics in murine tissues. Chem. Res. Toxicol. 23, 1796 (2010).
158. Z. M. Tao, B. Toms, J. Goodisman, and T. Asefa, Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs. ACS Nano 4, 789 (2010).
159. J. A. Champion and S. Mitragotri, Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. USA 103, 4930 (2006).
160. A. Wijaya, S. B. Schaffer, I. G. Pallares, and K. Hamad-Schifferli, Selective release of multiple DNA oligonucleotides from gold nanorods. ACS Nano 3, 80 (2009).
161. X. L. Huang, X. Teng, D. Chen, F. Q. Tang, and J. Q. He, The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 31, 438 (2010).
162. N. J. Hao, L. L. Li, Q. Zhang, X. L. Huang, X. W. Meng, and Y. Q. Zhang, The shape effect of PEGylated mesoporous silica nanoparticles on cellular uptake pathway in Hela cells. Micropor. Mesopor. Mater. 162, 14 (2012).
163. S. Kumari, S. MG, and S. Mayor, Endocytosis unplugged: Multiple ways to enter the cell. Cell Res. 20, 256 (2010).
164. J. L. Vivero-Escoto, I. I. Slowing, B. G. Trewyn, and V. S. Y. Lin, Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6, 1952 (2010).
165. G. Sahay, D. Y. Alakhova, and A. V. Kabanov, Endocytosis of nanomedicines. J. Control Release 145, 182 (2010).
166. N. G. Irani and E. Russinova, Receptor endocytosis and signaling in plants. Curr. Opin. Plant Biol. 12, 653 (2009).
167. L. Y. T. Chou, K. Ming, and W. C. W. Chan, Strategies for the intracellular delivery of nanoparticles. Chem. Soc. Rev. 40, 233 (2010).
168. G. J. Doherty and H. T. McMahon, Mechanisms of endocytosis. Annu. Rev. Biochem. 78, 857 (2009).
169. R. G. Parton and K. Simons, The multiple faces of caveolae. Nat. Rev. Mol. Cell Bio. 8, 185 (2007).
170. J. Lu, M. Liong, S. Sherman, T. Xia, M. Kovochich, and A. E. Nel, Mesoporous silica nanoparticles for cancer therapy: Energy-dependent cellular uptake and delivery of paclitaxel to cancer cells. Nanobiotechnology 3, 89 (2007).
171. W. Sun, N. Fang, B. G. Trewyn, M. Tsunoda, I. I. Slowing, and V. S. Y. Lin, Endocytosis of a single mesoporous silica nanoparticle into a human lung cancer cell observed by differential interference contrast microscopy. Anal. Bioanal. Chem. 391, 2119 (2008).
172. I. I. Slowing, B. G. Trewyn, and V. S. Y. Lin, Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J. Am. Chem. Soc. 128, 14792 (2006).
173. D. Napierska, L. C. J. Thomassen, D. Lison, J. A. Martens, and P. H. Hoet, The nanosilica hazard: Another variable entity. Part. Fibre Toxicol. 7, 39 (2010).
174. Y. S. Lin and C. L. Haynes, Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J. Am. Chem. Soc. 132, 4834 (2010).
175. Q. J. He, Z. W. Zhang, Y. Gao, J. L. Shi, and Y. P. Li, Intracellular localization and cytotoxicity of spherical mesoporous silica nanoand microparticles. Small 5, 2722 (2009).
176. M. J. D. Clift, S. Bhattajarhee, D. M. Brown, and V. Stone, The effects of serum on the toxicity of manufactured nanoparticles. Toxicol. Lett. 198, 358 (2010).
177. D. Napierska, L. C. J. Thomassen, V. Rabolli, D. Lison, L. Gonzalez, and M. Kirsch-Volders, Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 5, 846 (2009).
178. Y. Y. Ye, J. W. Liu, M. C. Chen, L. J. Sun, and M. B. Lan, In vitro toxicity of silica nanoparticles in myocardial cells. Environ. Toxicol. Pharmacol. 29, 131 (2010).
179. F. Lu, S. H. Wu, Y. Hung, and C. Y. Mou, Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5, 1408 (2009).
180. H. Nabeshi, T. Yoshikawa, K. Matsuyama, Y. Nakazato, A. Arimori, and M. Isobe, Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. Pharmazie 65, 199 (2010).
181. K. O. Yu, C. M. Grabinski, A. M. Schrand, R. C. Murdock, W. Wang, and B. Gu, Toxicity of amorphous silica nanoparticles in mouse keratinocytes. J. Nanopart. Res. 11, 15 (2008).
182. X. F. Yang, J. J. Liu, H. W. He, L. Zhou, C. M. Gong, and X. M. Wang, SiO2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells. Part. Fibre Toxicol. 7, 1 (2010).
183. Y. Y. Ye, J. W. Liu, J. H. Xu, L. J. Sun, M. C. Chen, and M. B. Lan, Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. Toxicol. Vitr. 24, 751 (2010).
184. I. I. Slowing, C. W. Wu, J. L. Vivero-Escoto, and V. S. Y. Lin, Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 5, 57 (2009).
185. Q. J. He, J. M. Zhang, J. L. Shi, Z. Y. Zhu, L. X. Zhang, and W. B. Bu, The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 31, 1085 (2010).
186. H. Meng, M. Liong, T. Xia, Z. X. Li, Z. X. Ji, and J. I. Zink, Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4, 4539 (2010).
187. D. B. Tada, E. Suraniti, L. M. Rossi, C. A. P. Leite, C. S. Oliveira, T. C. Tumolo, R. Calemczuk, T. Livache, and M. S. Baptista, Effect of lipid coating on the interaction between silica nanoparticles and membranes. J. Biomed. Nanotechnol. 10, 519 (2014).
188. Y. H. Bai, Y. Zhang, J. P. Zhang, Q. X. Mu, W. D. Zhang, and E. R. Butch, Repeated administrations of carbon nanotubes in male mice cause reversible testis damage without affecting fertility. Nat. Nanotechnol. 5, 683 (2010).
189. D. Guarnieri, A. Guaccio, S. Fusco, and P. A. Netti, Effect of serum proteins on polystyrene nanoparticle uptake and intracellular trafficking in endothelial cells. J. Nanopart. Res. 13, 4295 (2011).
190. I. I. Slowing, J. L. Vivero-Escoto, Y. N. Zhao, K. Kandel, C. Peeraphatdit, and B. G. Trewyn, Exocytosis of mesoporous silica nanoparticles from mammalian cells: From asymmetric cell-to-cell transfer to protein harvesting. Small 7, 1526 (2011).
191. Q. J. He, Z. W. Zhang, F. Gao, Y. P. Li, and J. L. Shi, In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: Effects of particle size and PEGylation. Small 7, 271 (2011).
192. X. X. He, H. L. Nie, K. M. Wang, W. H. Tan, X. Wu, and P. F. Zhang, In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal. Chem. 80, 9597 (2008).
193. T. Xia, M. Kovochich, M. Liong, H. Meng, S. Kabehie, and S. George, Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3, 3273 (2009).
194. M. J. Cho, W. S. Cho, M. Choi, S. J. Kim, B. S. Han, and S. H. Kim, The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol. Lett. 189, 177 (2009).
195. D. B. Warheit, M. C. Carakostas, D. P. Kelly, and M. A. Hartsky, Four-week inhalation toxicity study with Ludox colloidal silica in rats: Pulmonary cellular responses. Fund. Appl. Toxicol. 16, 590 (1991).
196. C. M. Sayes, K. L. Reed, K. P. Glover, K. A. Swain, M. L. Ostraat, and E. M. Donner, Changing the dose metric for inhalation toxicity studies: Short-term study in rats with engineered aerosolized amorphous silica nanoparticles. Inhal. Toxicol. 22, 348 (2010).
197. S. J. So, I. S. Jang, and C. S. Han, Effect of micro/nano silica particle feeding for mice. J. Nanosci. Nanotechnol. 8, 5367 (2008).
198. V. P. Chauhan, Z. Popović, O. Chen, J. Cui, D. Fukumura, and M. G. Bawendi, Fluorescent nanorods and nanospheres for realtime in vivo probing of nanoparticle shape-dependent tumor penetration. Angew. Chem. Int. Ed. 50, 11417 (2011).
199. V. Uskokovíc, Entering the era of nanoscience: Time to be so small Vuk Uskokovíc. J. Biomed. Nanotechnol. 9, 1441 (2013).
200. K. S. Finnie, D. J. Waller, F. L. Perret, A. M. Krause-Heuer, H. Q. Lin, and J. V. Hanna, Biodegradability of sol-gel silica microparticles for drug delivery. J. Sol-Gel Sci. Tech. 49, 12 (2008).
201. H. Yamada, C. Urata, Y. Aoyama, S. Osada, Y. Yamauchi, and K. Kuroda, Preparation of colloidal mesoporous silica nanoparticles with different diameters and their unique degradation behavior in static aqueous systems. Chem. Mater. 24, 1462 (2012).
202. N. Artzi, N. Oliva, C. Puron, S. Shitreet, S. Artzi, and A. bon Ramos, In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging. Nat. Mater. 10, 704 (2011).
203. V. Cauda, C. Argyo, and T. Bein, Impact of different PEGylation patterns on the long-term bio-stability of colloidal mesoporous silica nanoparticles. J. Mater. Chem. 20, 8693 (2010).
204. I. Izquierdo-Barba, M. Colilla, M. Manzano, and M. Vallet-Regí, In vitro stability of SBA-15 under physiological conditions. Micropor. Mesopor. Mater. 132, 442 (2010).
205. C. L. Dai, H. Guo, J. X. Lu, J. L. Shi, J. Wei, and C. S. Liu, Osteogenic evaluation of calcium/magnesium-doped mesoporous silica scaffold with incorporation of rhBMP-2 by synchrotron radiation-based μCT. Biomaterials 32, 8506 (2011).
206. Q. He, J. Shi, M. Zhu, Y. Chen, and F. Chen, The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid. Micropor. Mesopor. Mater. 131, 314 (2010).
207. N. J. Hao, H. Y. Liu, L. L. Li, D. Chen, L. F. Li, and F. Q. Tang, In vitro degradation behavior of silica nanoparticles under physiological conditions. J. Nanosci. Nanotechnol. 12, 6346 (2012).
208. M. R. C. Marques, R. Loebenberg, and M. Almukainzi, Simulated biological fluids with possible application in dissolution testing. J. Pharm. Sci. 101, 1212 (2011).
209. Y. L, Liu, S. Shah, and J. F. Tan, Computational modeling of nanoparticle targeted drug delivery. Rev. Nanosci. Nanotechnol. 1, 66 (2012).
210. M. Manzano and M. Vallet-Regí, New developments in ordered mesoporous materials for drug delivery. J. Mater. Chem. 20, 5593 (2010).
211. T. Lammers, F. Kiessling, W. E. Hennink, and G. Storm, Nanotheranostics and image-guided drug delivery: Current concepts and future directions. Mol. Pharm. 7, 1899 (2010).
212. J. J. Shi, A. R. Votruba, O. C. Farokhzad, and R. Langer, Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano Lett. 10, 3223 (2010).
213. S. S. Park, M. Santha Moorthy, S. W. Chu, F. P. Dong, W. P. Guo, and C. S. Ha, Controlled drug delivery of hollow mesostructured materials. Adv. Porous Mater. 1, 4 (2013).
214. W. W. Gao, J. M. Chan, and O. C. Farokhzad, pH-responsive nanoparticles for drug delivery. Mol. Pharm. 7, 1913 (2010).
215. J. M. Rosenholm and M. Lindén, Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications. J. Control. Release. 128, 157 (2008).
216. H. H. Kim, S. H. Kim, C. Y. Park, H. M. Lee, H. J. Park, and C. H. Kim, Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers. Adv. Mater. 22, 4280 (2010).
217. N. Ž. Knežević, B. G. Trewyn, and V. S. Y. Lin, Light- and pH-responsive release of doxorubicin from a mesoporous silica-based nanocarrier. Chem. Eur. J. 17, 3338 (2011).
218. J. Lu, M. Liong, J. I. Zink, and F. Tamanoi, Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3, 1341 (2007).
219. V. Cauda, C. Argyo, A. Schlossbauer, and T. Bein, Controlling the delivery kinetics from colloidal mesoporous silica nanoparticles with pH-sensitive gates. J. Mater. Chem. 20, 4305 (2010).
220. Q. N. Lin, Q. Huang, C. Y. Li, C. Y. Bao, Z. Z. Liu, and F. Y. Li, Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process. J. Am. Chem. Soc. 132, 10645 (2010).
221. L. Pasqua, F. Testa, R. Aiello, S. Cundari, and J. B. Nagy, Preparation of bifunctional hybrid mesoporous silica potentially useful for drug targeting. Micropor. Mesopor. Mater. 103, 166 (2007).
222. N. K. Mal, M. Fujiwara, and Y. Tanaka, Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 421, 350 (2003).
223. J. M. Rosenholm, E. Peuhu, L. T. Bate-Eya, J. E. Eriksson, C. Sahlgren, and M. Lindén, Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small 6, 1234 (2010).
224. M. Zhu, H. X. Wang, J. Y. Liu, H. L. He, X. G. Hua, and Q. J. He, A mesoporous silica nanoparticulate/β-TCP/BG composite drug delivery system for osteoarticular tuberculosis therapy. Biomaterials 32, 1986 (2011).
225. P. Aggarwal, J. B. Hall, C. B. McLeland, M. A. Dobrovolskaia, and S. E. McNeil, Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61, 428 (2009).
226. S. Hudson, J. Cooney, and E. Magner, Proteins in mesoporous silicates. Angew. Chem. Int. Ed. 47, 8582 (2008).
227. Y. N. Zhao, B. G. Trewyn, I. I. Slowing, and V. S. Y. Lin, Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. J. Am. Chem. Soc. 131, 8398 (2009).
228. I. I. Slowing, B. G. Trewyn, and V. S. Y. Lin, Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J. Am. Chem. Soc. 129, 8845 (2007).
229. G. Chandrasekar, M. Hartmann, and V. Murugesan, Immobilization of cytochrome c on the cylindrical mesoporous silica extrudates. J. Nanosci. Nanotechnol. 14, 2606 (2014).
230. J. Fan, W. Q. Shui, P. Y. Yang, X. Y. Wang, Y. M. Xu, and H. H. Wang, Mesoporous silica nanoreactors for highly efficient proteolysis. Chem. Eur. J. 11, 5391 (2005).
231. Q. H. Min, R. A. Wu, L. Zhao, H. Q. Qin, M. L. Ye, and J. J. Zhu, Size-selective proteolysis on mesoporous silica-based trypsin nanoreactor for low-MW proteome analysis. Chem. Commun. 46, 6144 (2010).
232. S. Muthukoori, N. Narayanan, M. S. S. Chandra, S. Sethuraman, and U. M. Krishnan, Enzyme-entrapped mesoporous silica for treatment of uric acid disorders. J. Biomed. Nanotechnol. 9, 907 (2013).
233. F. Torney, B. G. Trewyn, V. S. Y. Lin, and K. Wang, Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat. Nanotechnol. 2, 295 (2007).
234. S. M. Solberg and C. C. Landry, Adsorption of DNA into mesoporous silica. J. Phys. Chem. B 110, 15261 (2006).
235. F. Gao, P. Botella, A. Corma, J. Blesa, and L. Dong, Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA. J. Phys. Chem. B 113, 1796 (2009).
236. J. Singh, W. Mohammed-Saied, R. Kaur, and I. Badea, Nanoparticles in gene therapy: From design to clinical applications. Rev. Nanosci. Nanotechnol. 2, 275 (2013).
237. C. Hom, J. Lu, M. Liong, H. Z. Luo, Z. X. Li, and J. I. Zink, Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. Small 6, 1185 (2010).
238. Y. Han, D. Shchukin, P. Fernandes, R. Mutihac, and H. Möhwald, Mechanism and kinetics of controlled drug release by temperature stimuli responsive protein nanocontainers. Soft Matter. 6, 4942 (2010).
239. Y. C. Zhu, H. J. Liu, F. Li, Q. C. Ruan, H. Wang, and M. Fujiwara, Dipolar molecules as impellers achieving electric-field-stimulated release. J. Am. Chem. Soc. 132, 1450 (2010).
240. S. H. Hu, T. Y. Liu, H. Y. Huang, D. M. Liu, and S. Y. Chen, Magnetic-sensitive silica nanospheres for controlled drug release. Langmuir 24, 239 (2008).
241. H. J. Kim, H. Matsuda, H. Zhou, and I. Honma, Ultrasound-triggered smart drug release from a poly(dimethylsiloxane) - mesoporous silica composite. Adv. Mater. 18, 3083 (2006).
242. C. H. Lee, S. H. Cheng, I. P. Huang, J. S. Souris, C. S. Yang, and C. Y. Mou, Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew. Chem. Int. Ed. 49, 8214 (2010).
243. Z. Luo, K. Y. Cai, Y. Hu, L. Zhao, P. Liu, and L. Duan, Mesoporous silica nanoparticles end-capped with collagen: Redox-responsive nanoreservoirs for targeted drug delivery. Angew. Chem. Int. Ed. 50, 640 (2011).
244. A. Schlossbauer, J. Kecht, and T. Bein, Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica. Angew. Chem. Int. Ed. 48, 3092 (2009).
245. A. Bernardos, E. Aznar, M. D. Marcos, R. Martínez- Máñez, F. Sancenón, and J. Soto, Enzyme-responsive controlled release using mesoporous silica supports capped with lactose. Angew. Chem. Int. Ed. 48, 5884 (2009).
246. K. Patel, S. Angelos, W. R. Dichtel, A. Coskun, Y. W. Yang, and J. I. Zink, Enzyme-responsive snap-top covered silica nanocontainers. J. Am. Chem. Soc. 130, 2382 (2008).
247. T. Lebold, C. Jung, J. Michaelis, and C. Brauchle, Nanostructured silica materials as drug-delivery systems for doxorubicin: Single molecule and cellular studies. Nano Lett. 9, 2877 (2009).
248. H. H. P. Yiu, C. H. Botting, N. P. Botting, and P. A. Wright, Size selective protein adsorption on thiol-functionalised SBA-15 mesoporous molecular sieve. Phys. Chem. Chem. Phys. 3, 2983 (2001).
249. M. Vallet-Regí, F. Balas, M. Colilla, and M. Manzano, Bone-regenerative bioceramic implants with drug and protein controlled delivery capability. Prog. Solid State Chem. 36, 163 (2008).
250. P. Horcajada, A. Rámila, J. Pérez-Pariente, and M. Vallet-Regiì, Influence of pore size of MCM-41 matrices on drug delivery rate. Micropor. Mesopor. Mater. 68, 105 (2004).
251. F. Balas, M. Manzano, M. Colilla, and M. Vallet-Regí, L-Trp adsorption into silica mesoporous materials to promote bone formation. Acta Biomater. 4, 514 (2008).
252. F. Balas, M. Manzano, P. Horcajada, and M. Vallet-Regí, Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J. Am. Chem. Soc. 128, 8116 (2006).
253. M. Vallet-Regi, M. Colilla, and I. Izquierdo-Barba, Bioactive mesoporous silicas as controlled delivery systems: Application in bone tissue regeneration. J. Biomed. Nanotechnol. 4, 400 (2008).
254. B. Munoz, A. Ramila, J. Perez-Pariente, Vranjes-Djuric, I. Diaz, and M. Vallet-Regí, MCM-41 organic modification as drug delivery rate regulator. Chem. Mater. 41, 500 (2003).
255. J. Gu, S. Su, Y. Li, Q. He, J. Zhong, and J. Shi, Surface modification-complexation strategy for cisplatin loading in mesoporous nanoparticles. J. Phys. Chem. Lett. 1, 3446 (2010).
256. K. P. Singh, P. Panwar, P. Kohli, and Sanjesh, Liposomemesoporous silica nanoparticles fused cores: A safer mode of drug carrier. J. Biomed. Nanotechnol. 7, 60 (2011).
257. L. L. Li, X. L. Huang, T. L. Liu, H. Y. Liu, N. J. Hao, and D. Chen, Overcoming multidrug resistance with mesoporous silica nanorods as nanocarrier of doxorubicin. J. Nanosci. Nanotechnol. 12, 4458 (2012).
258. A. E. Nel, L. Mädler, D. Velegol, T. Xia, E. M. V Hoek, and P. Somasundaran, Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8, 543 (2009).
259. A. Vinu and K. Ariga, New ideas for mesoporous materials. Adv. Porous Mater. 1, 63 (2013).
260. C. D. Walkey and W. C. W. Chan, Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 41, 2780 (2012).
261. X. W. Lou, L. A. Archer, and Z. C. Yang, Hollow micro-/nanostructures: Synthesis and applications. Adv. Mater. 20, 3987 (2008).
262. T. L. Liu, H. Y. Liu, C. H. Fu, L. L. Li, D. Chen, and Y. Q. Zhang, Silica nanorattle with enhanced protein loading: A potential vaccine adjuvant. J. Colloid Interf. Sci. 400, 168 (2013).
263. L. L. Li, Y. Q. Zhang, N. J. Hao, D. Chen, and F. Q. Tang, Fabrication of PLGA coated silica nanorattle for controlling the drug release behavior. Chin. Sci. Bull. 57, 3631 (2012).
264. Y. Zhu, J. Shi, W. Shen, X. Dong, J. Feng, and M. Ruan, Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. Angew. Chem. Int. Ed. 44, 5083 (2005).
265. Y. Zhao, L. N. Lin, Y. Lu, S. F. Chen, L. Dong, and S. H. Yu, Templating synthesis of preloaded Doxorubicin in hollow mesoporous silica nanospheres for biomedical applications. Adv. Mater. 22, 5255 (2010).
266. Y. L. Zhao and H. S. Nalwa (eds.), Nanotoxicology: Interactions of Nanomterials with Biological Systems, American Scientific Publishers, Los Angeles, CA (2007).
267. Y. Chen, H. R. Chen, and J. L. Shi, Engineering of hollow mesoporous nanoparticles for biomedical applications. Adv. Porous Mater. 1, 34 (2013).
268. T. L. Liu, L. L. Li, X. Teng, X. L. Huang, H. Y. Liu, and D. Chen, Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 32, 1657 (2011).
269. C. H. Fu, T. L. Liu, L. L. Li, H. Y. Liu, D. Chen, and F. Q. Tang, The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials 34, 2565 (2013).
270. T. L. Liu, H. Y. Liu, C. H. Fu, L. L. Li, D. Chen, and Y. Q. Zhang, Smaller silica nanorattles reabsorbed by intestinal aggravate multiple organs damage. J. Nanosci. Nanotechnol. 13, 6506 (2013).
271. T. L. Liu, L. L. Li, C. H. Fu, H. Y. Liu, D. Chen, and F. Q. Tang, Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles. Biomaterials 33, 2399 (2012).
272. M. S. Bhojani, M. Van Dort, A. Rehemtulla, and B. D. Ross, Targeted imaging and therapy of brain cancer using theranostic nanoparticles. Mol. Pharm. 7, 1921 (2010).
273. Z. Chen, Small-molecule delivery by nanoparticles for anticancer therapy. Trends Mol. Med. 16, 594 (2010).
274. E. Ruoslahti, S. N. Bhatia, and M. J. Sailor, Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 188, 759 (2010).
275. R. K. Jain and T. Stylianopoulos, Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 7, 653 (2010).
276. K. Maruyama, Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv. Drug Deliv. Rev. 63, 161 (2011).
277. C. Minelli, S. B. Lowe, and M. M. Stevens, Engineering nanocomposite materials for cancer therapy. Small 6, 2336 (2010).
278. K. Greish, Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol. Biol. 624, 25 (2010).
279. D. P. O'Neal, L. R. Hirsch, N. J. Halas, J. D. Payne, and J. L. West, Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 209, 171 (2004).
280. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D. A. Berk, and V. P. Torchilin, Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res. 55, 3752 (1995).
281. M. E. Fox, F. C. Szoka, and J. M. J. Fréchet, Soluble polymer carriers for the treatment of cancer: The importance of molecular architecture. Acc. Chem. Res. 42, 1141 (2009).
282. L. L. Li, F. Q. Tang, H. Y. Liu, T. L. Liu, N. J. Hao, and D. Chen, In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. ACS Nano 4, 6874 (2010).
283. F. P. Gao, L. L. Li, T. L. Liu, N. J. Hao, H. Y. Liu, and L. F. Tan, Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects. Nanoscale 4, 3365 (2012).
284. F. P. Gao, L. L. Li, C. H. Fu, L. Y. Nie, D. Chen, and F. Q. Tang, LHRH-PE40 fusion protein tethered silica nanorattles for imaging-guided tumor-specific drug delivery and bimodal therapy. Adv. Mater. 25, 5508 (2013).
285. L. L. Li, Y. Q. Guan, H. Y. Liu, N. J. Hao, T. L. Liu, and X. W. Meng, Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano 5, 7462 (2011).
286. D. C. Niu, Z. Ma, Y. S. Li, and J. L. Shi, Synthesis of core-shell structured dual-mesoporous silica spheres with tunable pore size and controllable shell thickness. J. Am. Chem. Soc. 132, 15144 (2010).
287. J. E. Lee, N. Lee, T. Kim, J. Kim, and T. Hyeon, Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc. Chem. Res. 44, 893 (2011).
288. W. Zhao, J. Gu, L. Zhang, H. Chen, and J. Shi, Fabrication of uniform magnetic nanocomposite spheres with a magnetic core/mesoporous silica shell structure. J. Am. Chem. Soc. 127, 8916 (2005)
289. Q. Liu, J. X. Zhang, W. L. Xia, and H. C. Gu, Towards magnetic-enhanced cellular uptake, MRI and chemotherapeutics delivery by magnetic mesoporous silica nanoparticles. J. Nanosci. Nanotechnol. 12, 7709 (2012).
290. H. Y. Liu, T. L. Liu, X. L. Wu, L. L. Li, L. F. Tan, and D. Chen, Targeting gold nanoshells on silica nanorattles: A drug cocktail to fight breast tumors via a single irradiation with near-infrared laser light. Adv. Mater. 24, 755 (2012).
291. H. Y. Liu, T. L. Liu, L. L. Li, N. J. Hao, L. F. Tan, and X. W. Meng, Size dependent cellular uptake. In vivo fate and light-heat conversion efficiency of gold nanoshells on silica nanorattles. Nanoscale 4, 3523 (2012).
292. H. Y. Liu, T. L. Liu, H. Wang, L. L. Li, L. F. Tan, and C. H. Fu, Impact of PEGylation on the biological effects and light heat conversion efficiency of gold nanoshells on silica nanorattles. Biomaterials 34, 6967 (2013).
293. S. Fukuzumi and Y. Yamada, Shape- and size-controlled nanomaterials for artificial photosynthesis. ChemSusChem. 6, 1834 (2013).
294. S. Fukuzumi, K. Doi, A. Itoh, T. Suenobu, K. Ohkubo, and Y. Yamada, Formation of a long-lived electron-transfer state in mesoporous silica-alumina composites enhances photocatalytic oxygenation reactivity. Proc. Natl. Acad. Sci. USA 109, 15572 (2012).
295. P. Mohan and N. Rapoport, Doxorubicin as a molecular nanotheranostic agent: Effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol. Pharm. 7, 1959 (2010).
296. X. L. Huang, J. Zhuang, X. Teng, L. L. Li, D. Chen, and X. Y. Yan, The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species. Biomaterials 31, 6142 (2010).